Potency and Bactericidal Activity of Iclaprim against Recent Clinical Gram-Positive Isolates

Antimicrobial Agents and Chemotherapy
2009.0

Abstract

The in vitro activity of iclaprim, a novel diaminopyrimidine derivative, was evaluated against 5,937 recent gram-positive clinical isolates collected in the United States and Europe. Iclaprim demonstrated potent activity against Staphylococcus aureus (including methicillin-resistant S. aureus [MRSA]), beta-hemolytic Streptococcus spp., and Enterococcus faecalis strains tested. In addition, iclaprim exhibited bactericidal activity against all S. aureus strains tested, including MRSA.

Knowledge Graph

Similar Paper

Potency and Bactericidal Activity of Iclaprim against Recent Clinical Gram-Positive Isolates
Antimicrobial Agents and Chemotherapy 2009.0
In Vitro Bactericidal Activity of Iclaprim in Human Plasma
Antimicrobial Agents and Chemotherapy 2009.0
Iclaprim, a novel diaminopyrimidine with potent activity on trimethoprim sensitive and resistant bacteria
Bioorganic & Medicinal Chemistry Letters 2003.0
In Vitro Activity of Iclaprim against Respiratory and Bacteremic Isolates of Streptococcus pneumoniae
Antimicrobial Agents and Chemotherapy 2009.0
Efficacy of Iclaprim against Wild-Type and Thymidine Kinase-Deficient Methicillin-Resistant Staphylococcus aureus Isolates in an In Vitro Fibrin Clot Model
Antimicrobial Agents and Chemotherapy 2009.0
Potent antimicrobial activity of 3-(4,5-diaryl-1H-imidazol-2-yl)-1H-indole derivatives against methicillin-resistant Staphylococcus aureus
Bioorganic & Medicinal Chemistry Letters 2010.0
In Vitro Profiling of Ceftaroline against a Collection of Recent Bacterial Clinical Isolates from across the United States
Antimicrobial Agents and Chemotherapy 2008.0
Synthesis and antimicrobial activity of clindamycin analogs: pirlimycin, a potent antibacterial agent
Journal of Medicinal Chemistry 1984.0
Synthesis and antibacterial activities of a novel alkylide: 3-O-(3-aryl-2-propargyl) and 3-O-(3-aryl-2-propenyl)clarithromycin derivatives
Bioorganic & Medicinal Chemistry Letters 2010.0
In Vitro Activity of Telavancin against Resistant Gram-Positive Bacteria
Antimicrobial Agents and Chemotherapy 2008.0